$63.50 +0.09 (%) NuVasive Inc - NASDAQ

Dec. 2, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Morning Call For October 26, 2016

    TalkMarkets | Oct. 26, 2016 | 07:47AM EST
  2. Benzinga's Top Upgrades

    Benzinga | Dec. 11, 2015 | 08:50AM EST
  3. NuVasive Receives First Ever FDA 510(k) Clearance of Cervical Corpectomy Cage

    Benzinga | Oct. 12, 2015 | 06:00AM EST
  4. Benzinga's Top Upgrades

    Benzinga | Oct. 6, 2015 | 08:16AM EST
  5. Vanguard Health Care Fund Buys Two New Stakes in Second Quarter

    GuruFocus | Aug. 6, 2015 | 17:14PM EST
  6. NuVasive Hits 7-Year High After Q2 Earnings Beat

    IBD | Jul. 29, 2015 | 10:04AM EST
  7. Weekly CEO Buys Highlight: BRKR, GAIN, LUB, NUVA, FGP

    GuruFocus | Jun. 21, 2015 | 22:32PM EST
  8. Weekly CEO Buys Highlight: TPC, GBDC, NUVA, TEGP, JOY

    GuruFocus | Jun. 14, 2015 | 17:00PM EST
  9. Weekly CEO Buys Highlight: TPC, NUVA, PHII, GBDC, ARO

    GuruFocus | Jun. 10, 2015 | 11:21AM EST
  10. Benzinga's Top #PreMarket Losers

    Benzinga | Jun. 3, 2015 | 07:17AM EST
  11. Weekly CEO Buys Highlight: NUVA, HK, BKFS, PODD, CLF

    GuruFocus | Jun. 2, 2015 | 10:50AM EST
  12. Medtronic Prelim Q4 Beats Estimates On Cardio Sales

    IBD | May. 19, 2015 | 09:59AM EST
  13. Benzinga's Top Downgrades

    Benzinga | Apr. 15, 2015 | 08:15AM EST
  14. Spinal Products Firm NuVasive Ripe For Expansion

    IBD | Jan. 8, 2015 | 15:17PM EST
  15. NuVasive Focused On Surgeon Support And Showcasing Industry-Leading Products At North American Spine Society 29th Annual Meeting

    Benzinga | Nov. 10, 2014 | 16:25PM EST
  16. Medical-Device Stocks Could Benefit From Tax Repeal

    IBD | Nov. 5, 2014 | 17:42PM EST
  17. NuVasive(R) Demonstrates Expanding EMEA Business at Eurospine 2014 With Surgeon Workshops and ...

    GuruFocus | Oct. 15, 2014 | 11:15AM EST
  18. Fellow orthopedics maker

    IBD | Apr. 24, 2014 | 17:36PM EST
  19. Zimmer To Acquire Biomet; Stock Soars

    IBD | Apr. 24, 2014 | 11:21AM EST
  20. NuVasive Announces $30M Unfavorable Jury Verdict for Use of Trade-Name 'NeuroVision' 8-K

    Benzinga | Apr. 4, 2014 | 05:21AM EST
  21. NuVasive Up After Q4 Beat, Despite Cautious Guidance

    IBD | Mar. 4, 2014 | 12:01PM EST
  22. Ukraine Unrest Sparks Selling But Some Biotechs Firm Up

    IBD | Mar. 3, 2014 | 16:22PM EST
  23. Earnings Scheduled For March 3, 2014

    Benzinga | Mar. 3, 2014 | 04:42AM EST
  24. Stocks Hitting 52-Week Highs

    Benzinga | Jan. 16, 2014 | 10:32AM EST
  25. NuVasive pops to 3-year high

    IBD | Jan. 15, 2014 | 18:46PM EST
  26. Mid-Afternoon Market Update: Markets Nearly Erase Early Year Losses as The ExOne Continues to Drop

    Benzinga | Jan. 15, 2014 | 15:59PM EST
  27. Mid-Day Market Update: Dow Jumps 120 Points; Fastenal Shares Drop On Downbeat Earnings

    Benzinga | Jan. 15, 2014 | 13:44PM EST
  28. NuVasive Preliminary Q4 Sales Beat, Stock Jumps

    IBD | Jan. 15, 2014 | 12:44PM EST
  29. Mid-Morning Market Update: Markets Rise; Bank of America Profit Beats Estimates

    Benzinga | Jan. 15, 2014 | 11:31AM EST
  30. Benzinga's Volume Movers

    Benzinga | Jan. 15, 2014 | 10:33AM EST
  31. Stocks Hitting 52-Week Highs

    Benzinga | Oct. 30, 2013 | 09:23AM EST
  32. UPDATE: Goldman Sachs Downgrades NuVasive as Industry Headwinds, Valuation Pose Downside Risk

    Benzinga | Oct. 14, 2013 | 10:29AM EST
  33. Benzinga's Top Downgrades

    Benzinga | Oct. 14, 2013 | 06:46AM EST
  34. Benzinga's Top Initiations

    Benzinga | Aug. 8, 2013 | 08:18AM EST
  35. Market Wrap For Wednesday, July 31: Stocks Mostly Unchanged Despite Upbeat Data

    Benzinga | Jul. 31, 2013 | 15:23PM EST
  36. Mid-Afternoon Market Update: Fed Leaves Rates Unchanged; Green Dot Rises

    Benzinga | Jul. 31, 2013 | 14:45PM EST
  37. Mid-Afternoon Market Update: NuVasive Rises While EXCO Resourced Drops

    Benzinga | Jan. 9, 2013 | 08:52AM EST
  38. Mid-Day Market Update: Markets Remain Up, Dynavax Continues Rally

    Benzinga | Jan. 9, 2013 | 07:19AM EST
  39. Benzinga's Top Upgrades

    Benzinga | Jan. 9, 2013 | 00:11AM EST
  40. NuVasive Announces First Patient in the United States Treated With the PCM Cervical Disc Following FDA Approval

    Benzinga | Dec. 20, 2012 | 07:40AM EST
  41. NuVasive(R) Announces Release of $62.5M From Escrow Following Appeals Court Victory

    Benzinga | Dec. 13, 2012 | 09:50AM EST
  42. NuVasive to Release $62.5M from Escrow Following Appeals Court Win

    Benzinga | Dec. 13, 2012 | 09:49AM EST
  43. Covidien Stock Rises After Earnings Beat Estimates

    IBD | Nov. 9, 2012 | 03:36AM EST
  44. NuVasive Announces PMA Approval of the PCM(R) Cervical Disc System

    Benzinga | Oct. 26, 2012 | 05:02AM EST
  45. NuVasive Inc. Reports Operating Results (10-Q)

    GuruFocus | Oct. 25, 2012 | 02:02AM EST
  46. Benzinga's Top Downgrades

    Benzinga | Oct. 25, 2012 | 00:27AM EST
  47. UPDATE: Goldman Sachs Reduces PT to $16 on NuVasive on Sales Outlook

    Benzinga | Oct. 24, 2012 | 07:22AM EST
  48. Intuitive Surgical Stock Rebounds From Q3 Dive

    IBD | Oct. 17, 2012 | 04:09AM EST
  49. Intuitive Surgical Stock Upgraded Ahead Of Q3 Report

    IBD | Oct. 15, 2012 | 04:12AM EST
  50. FDA Ruling on Artificial Disc Boosts Globus Medical

    IBD | Oct. 10, 2012 | 06:29AM EST
Trading Center